相关实验视频
Updated: May 2, 2026

10:42
A Free-breathing fMRI Method to Study Human Olfactory Function
Published on: July 30, 2017
9.0K
阿尔茨海默病连续体中的嗅觉功能网络:休息状态fMRI研究
Daniela Ballotta1, Claudia Casadio1, Manuela Tondelli1,2
1Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Frontiers in aging neuroscience
|January 29, 2026
概括
轻度认知障碍 (MCI) 患者的嗅觉功能障碍预测了阿尔茨海默氏症 (AD) 痴呆症的进展. 改变了嗅觉皮层的功能连接,特别是与角环,与嗅觉性能相关,表明疾病的进展.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 医疗成像医学成像
背景情况:
- 嗅觉功能障碍是阿尔茨海默病 (AD) 连续性的早期指标.
- 嗅觉的变化可以在AD痴呆症的临床症状之前发生.
- 轻度认知障碍 (MCI) 代表了一个过渡阶段,发展到AD的速度各不相同.
研究的目的:
- 为了研究MCI患者的嗅觉皮层功能连接.
- 为了将功能连接与嗅觉表现相关联.
- 为了确定从MCI转化为AD痴呆症的预测因素.
主要方法:
- 在30名MCI患者中使用Sniffin' Sticks评估了嗅觉能力.
- 使用静止状态功能磁共振成像 (fMRI) 来分析嗅觉皮层连接.
- 与嗅觉测试得分和临床随访相关的功能连接数据 (转换为AD).
主要成果:
- 转换患者显示嗅觉皮层与后带皮层的连接性增加.
- 转换器患者表现出与中间环状皮质,补充运动区域和左侧前/后中心旋转器的连接性下降.
- 在转换器中观察到嗅觉皮层和左角环之间的负功能连接性减少,与嗅觉歧视得分负相关.
结论:
- 嗅觉皮层的功能连接性改变存在于患有MCI的患有AD风险的患者中.
- 嗅觉皮层的连接模式可以作为AD进展的早期标志物.
- 嗅觉表现和角性环结合性可能表明神经退行性疾病的发展轨迹.
相关概念视频
Olfaction
40.5K
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
The olfactory receptors are embedded in the cilia of the...
40.5K
Olfactory Receptors: Location and Structure
10.5K
The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
10.5K
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35

